What is Forest Neurotech?
Forest Neurotech operates as a specialized nonprofit entity dedicated to the advancement of neuroscience through innovative hardware solutions. Their primary offering, the Forest 1, represents a breakthrough in compact, research-grade ultrasound scanning technology. By prioritizing less invasive methodologies, the company addresses critical bottlenecks in current neuroscientific research, providing scholars and clinicians with precise tools for mapping neural activity. The firm's market position is defined by its commitment to democratizing access to high-fidelity ultrasonic neural interfaces, effectively bridging the gap between complex laboratory equipment and scalable, user-centric research tools.
How much funding has Forest Neurotech raised?
Forest Neurotech has raised a total of $14M across 1 funding round:
Other Financing Round
$14M
Other Financing Round (2024): $14M with participation from Convergence Research
Key Investors in Forest Neurotech
Convergence Research
Convergence Research is a specialized firm focused on delivering high-accuracy data solutions and research results, often supporting complex analytical requirements through proprietary sourcing and scalable technology.
What's next for Forest Neurotech?
The recent capital allocation is expected to catalyze the next phase of the company's growth trajectory, specifically focusing on the refinement of the Forest 1 platform and the expansion of its research-grade imaging capabilities. As the organization transitions into a more mature operational phase, the strategic focus will likely shift toward scaling production and fostering collaborative partnerships within the global neuroscience community. By leveraging this financial backing, Forest Neurotech aims to solidify its role as a foundational provider of BCI infrastructure, ultimately driving long-term innovation in the study of human brain function and the development of next-generation neuromodulation therapies.
See full Forest Neurotech company page
